Paolo Pucci

Paolo Pucci is a declared insider at 3 companies (senior executive); the most frequent names are Arqule Inc, West Pharmaceutical Services Inc and Dyax Corp. In total, 33 filings cover trades dated from 13 January 2016 to 6 May 2025.

Purchases make up the whole of the open-market record (9 purchases, €92k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 12 share grants and 10 option exercises.

A typical purchase (the median) is worth €2,880. 2 out of 9 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

The newest entry dates from 8 May 2025: a share grant, in West Pharmaceutical Services Inc. The most recent open-market purchase was published on 18 May 2018, 3,078 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.